163 related articles for article (PubMed ID: 28107281)
1. Psoriasis Induced by Vedolizumab.
Sody E; Körber A
Inflamm Bowel Dis; 2017 Feb; 23(2):E9-E11. PubMed ID: 28107281
[No Abstract] [Full Text] [Related]
2. Acute Pancreatitis in a Patient With Ulcerative Colitis on Vedolizumab.
Lin E; Katz S
Inflamm Bowel Dis; 2020 Apr; 26(5):e44. PubMed ID: 32100867
[No Abstract] [Full Text] [Related]
3. Cutaneous Vasculitis Associated With Vedolizumab in Ulcerative Colitis.
de Freitas LF; Feitosa MR; Féres O; Parra RS
Inflamm Bowel Dis; 2021 Jan; 27(2):e15-e17. PubMed ID: 33048114
[No Abstract] [Full Text] [Related]
4. Acneiform eruption induced by vedolizumab.
Magdaleno-Tapial J; Ferrer-Guillén B; Valenzuela-Oñate C; Esteve-Martínez A
Dermatol Online J; 2018 Oct; 24(10):. PubMed ID: 30677821
[TBL] [Abstract][Full Text] [Related]
5. Hidradenitis Suppurativa Caused by Vedolizumab.
Licata G; Gambardella A; De Rosa A; Calabrese G; Alfano R; Argenziano G
Dermatitis; 2021 Jan-Feb 01; 32(1):e23-e24. PubMed ID: 33208632
[No Abstract] [Full Text] [Related]
6. Vedolizumab-Associated Pancreatitis in Paediatric Ulcerative Colitis: Functional Selectivity of the α4β7integrin and MAdCAM-1 Pathway?
Lopez RN; Gupta N; Lemberg DA
J Crohns Colitis; 2018 Mar; 12(4):507-508. PubMed ID: 29228226
[No Abstract] [Full Text] [Related]
7. Vedolizumab-induced acne in inflammatory bowel disease.
Gilhooley E; Doherty G; Lally A
Int J Dermatol; 2018 Jun; 57(6):752-753. PubMed ID: 29654701
[No Abstract] [Full Text] [Related]
8. Pharmacodynamic assessment of vedolizumab for the treatment of ulcerative colitis.
McLean LP; Cross RK
Expert Opin Drug Metab Toxicol; 2016 Jul; 12(7):833-42. PubMed ID: 27096357
[TBL] [Abstract][Full Text] [Related]
9. Vedolizumab-Associated Acute Respiratory Distress Syndrome.
Nambiar S; Karippot A; Oliver T
Am J Ther; 2018; 25(5):e592-e593. PubMed ID: 29189313
[No Abstract] [Full Text] [Related]
10. Vedolizumab-induced acute pancreatitis: the first reported clinical case.
Picardo S; So K; Venugopal K; Chin M
BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29305366
[TBL] [Abstract][Full Text] [Related]
11. Excipient Exception: A Complication of Infliximab and Vedolizumab Infusions for Ulcerative Colitis.
Dalal RS; Goksel B; Hamilton MJ
Dig Dis Sci; 2023 May; 68(5):1709-1713. PubMed ID: 36929242
[No Abstract] [Full Text] [Related]
12. Vedolizumab-induced cholestatic liver injury.
Rojas-Feria M; Rodríguez-Fernández M; Castro-Fernández M; Suárez-García E
Gastroenterol Hepatol; 2022 Jan; 45(1):64-65. PubMed ID: 33248173
[No Abstract] [Full Text] [Related]
13. Severe erosive gingivostomatitis in a patient treated by vedolizumab.
Semeria L; Dadban A; Brazier F; Fumery M; Ikoli JF; Arnault JP; Adas A; Dairi M; Lok C; Chaby G
Dermatol Online J; 2020 Oct; 26(10):. PubMed ID: 33147674
[TBL] [Abstract][Full Text] [Related]
14. Safety of vedolizumab in the treatment of Crohn's disease and ulcerative colitis.
Hagan M; Cross RK
Expert Opin Drug Saf; 2015; 14(9):1473-9. PubMed ID: 26138111
[TBL] [Abstract][Full Text] [Related]
15. [Current position on Vedolizumab for ulcerative colitis and Crohn's disease].
Schreiber S; Dignass AU; Hartmann H; Kruis W; Rogler G; Siegmund B; Stallmach A; Witte C; Bokemeyer B
Z Gastroenterol; 2015 Jun; 53(6):591-602. PubMed ID: 26016456
[TBL] [Abstract][Full Text] [Related]
16. Psoriasiform dermatitis in a girl with ulcerative colitis receiving vedolizumab.
Tsuchiya M; Hashimoto R; Arai K; Yoshida K
J Dermatol; 2022 Jun; 49(6):e191-e192. PubMed ID: 35199379
[No Abstract] [Full Text] [Related]
17. Pustular psoriasis induced by infliximab.
Thurber M; Feasel A; Stroehlein J; Hymes SR
J Drugs Dermatol; 2004; 3(4):439-40. PubMed ID: 15303790
[TBL] [Abstract][Full Text] [Related]
18. Vedolizumab-induced acute interstitial lung injury in a 39-year-old male with ulcerative colitis.
Rizos ED; Antonogiannaki EM; Chatzidakis A; Kallieri M; Tsilogianni Z; Manali ED; Economopoulos N; Triantafyllou K; Papiris SA; Polymeros D
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e1057-e1059. PubMed ID: 34074983
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of vedolizumab in the treatment of ulcerative colitis.
Domènech E; Gisbert JP
Gastroenterol Hepatol; 2016 Dec; 39(10):677-686. PubMed ID: 26948838
[TBL] [Abstract][Full Text] [Related]
20. The safety of vedolizumab for the treatment of ulcerative colitis.
Novak G; Hindryckx P; Khanna R; Jairath V; Feagan BG
Expert Opin Drug Saf; 2017 Apr; 16(4):501-507. PubMed ID: 28276855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]